Ajinomoto Co., Ltd.

Nobukazu Ono

Naoyuki Okamoto

Masahiko Higashiyama

Hiroshi Yamamoto

Toshihiko Ando

Akira Imaizumi

Shinichi Ohkawa

Takahiko Muramatsu

Yohei Miyagi

Ryosei Sakai

Atsuko Shinhara

Fumio Imamura

Shinya Kikuchi

Koichi Shiraishi

Nobuyasu Fukutake

Kazuhiro Katayama

Makoto Ueno

A method of evaluating pancreatic cancer includes (I) an obtaining step of obtaining amino acid concentration data on a concentration value of an amino acid in blood collected from a subject to be evaluated, and (II) an evaluating step of evaluating a state of pancreatic cancer in the subject by calculating a value of a formula using the amino acid concentration data of the subject obtained at the obtaining step and the formula previously established for evaluating the state of pancreatic cancer, including an explanatory variable to be substituted with the concentration value of the amino acid. The amino acid concentration data includes the concentration values of at least two amino acids of Asn, His, Thr, Ala, Cit, Arg, Tyr, Val, Met, Lys, Trp, Gly, Pro, Orn, Ile, Leu, Phe, Ser, and Gln, and the formula includes at least two explanatory variables to be substituted with the concentration values of at least two amino acids of Asn, His, Thr, Ala, Cit, Arg, Tyr, Val, Met, Lys, Trp, Gly, Pro, Orn, Ile, Leu, Phe, Ser, and Gln.

Method for evaluating pancreatic cancer, pancreatic cancer evaluating apparatus, pancreatic cancer evaluating method, pancreatic cancer evaluating program product, pancreatic cancer evaluating system and information communication terminal apparatus

According to the method of evaluating lung cancer, amino acid concentration data on the concentration value of amino acid in blood collected from a subject to be evaluated is measured, and a lung cancer state in the subject is evaluated based on the concentration value of at least one of Orn, Lys, ABA, Arg, Glu, His, Tau, Pro, Ala, Cit and Ile contained in the measured amino acid concentration data of the subject.

Lung cancer evaluating apparatus, method, system, and program and recording medium therefor

The present invention relates to a method for inhibiting cell growth whereby a thymidine kinase gene is introduced and expressed in a cell followed by administering a (&minus;)-9-&lsqb;1,S,2&prime;R-bis(hydroxymethyl)cyclopropan-1&prime;-yl&rsqb;methylguanine in an amount sufficient to inhibit cell growth.

Method for treatment in gene therapy and use of guanine derivative therefor

Growing community of inventors

Kanagawa, Japan

Nobukazu Ono